Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new perspective on quality.

N J Schroeder

    Physician Executive
    |April 8, 1992
    PubMed
    Summary
    This summary is machine-generated.

    The U.S. spends the most on healthcare globally, yet achieves poorer outcomes. This article examines payer perspectives on improving healthcare quality and efficiency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vitamin D analogues: how do they differ and what is their clinical role?

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
    Same author

    Metabolism of a 20-methyl substituted series of vitamin D analogs by cultured human cells: apparent reduction of 23-hydroxylation of the side chain by the 20-methyl group.

    Biochemical pharmacology·2001
    Same author

    Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2000
    Same author

    What's new in vitamin D for the nephrologist?

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2000
    Same author

    Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines.

    Biological & pharmaceutical bulletin·2000
    Same author

    Effects of new analogues of vitamin D on bone cells: implications for treatment of uremic bone disease.

    Kidney international·1999
    Same journal

    Encore! Encore!

    Physician executive·2014
    Same journal

    The medical loss ratio: a core component of reform.

    Physician executive·2014
    Same journal

    Avoid the breach: put data security measures in place.

    Physician executive·2014
    Same journal

    Hospitals of excellence and geography: an update.

    Physician executive·2014
    Same journal

    Collegial intervention and the disruptive physician.

    Physician executive·2014
    Same journal

    Standardizing electronic medical record documentation.

    Physician executive·2014
    See all related articles

    Area of Science:

    • Health Services Research
    • Healthcare Economics
    • Public Health Policy

    Background:

    • The United States healthcare sector represents a significant portion of the national economy, consuming 13% of the gross national product ($800 billion annually).
    • Despite the highest per capita healthcare expenditure globally, the U.S. exhibits inferior health outcomes compared to other developed nations.
    • The current American healthcare system is characterized by high costs, limited access, frequent failures, excessive/inappropriate care, and insufficient data on treatment effectiveness.

    Purpose of the Study:

    • To explore current payers' perspectives on the potential for quality improvement within the U.S. healthcare system.
    • To identify key areas where payers believe quality enhancement is most feasible and impactful.

    Main Methods:

    Related Experiment Videos

  • This article presents a discussion based on payers' viewpoints.
  • Analysis of perspectives on current healthcare system inefficiencies and quality gaps.

    • Main Results:

    • Payers identify significant issues including high costs, access barriers, and suboptimal care delivery.
    • There is a recognized need for greater understanding of treatment effectiveness to guide improvements.

    Conclusions:

    • Addressing the identified shortcomings in the U.S. healthcare system is crucial for enhancing quality and value.
    • Payers' insights are vital for driving meaningful quality improvement initiatives in American healthcare.